|
|
46563 Fremont Boulevard
Fremont, CA 94538 USA
phone:510-252-9500
fax:510-252-9515
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.flowmedica.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Minimally invasive intravascular systems for implementing targeted renal therapy. |
|
| Management |
| Jeff Elkins, President and CEO; Samir Patel, Director of Marketing; Burt Goodson, Manager, Director, Scientific Affairs and Technology; Aurelio Valencia, Manager, Senior Operations Manager |
| |
|
|
| |
|
| Keywords |
| minimally invasive, intravascular, targeted renal therapy, kidney, renal artery |
|
|
|
| Description |
|
FlowMedica, Inc.develops novel, proprietary, minimally invasive intravascular systems for implementing targeted renal therapy - the direct delivery of certain medications and other therapeutic agents to the kidneys via the renal arteries.
|
|
| Products / Services |
The company's initial product, the Benephit CV Infusion System, is a selective infusion catheter system for TRT. The device delivers therapeutic agents directly into the renal arteries through a dedicated infusion catheter while allowing simultaneous coronary or peripheral procedures through a single vessel access site in the femoral artery. FlowMedica's second platform, the Benephit PV Infusion System, is an FDA 510(k)-cleared system that features a reduced profile, increased flexibility and a variety of lengths to allow for access through sites that include the brachial and radial arteries, as well as greater patient mobility and ease in providing therapy once the patient leaves the interventional laboratory.
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members